Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma. - Wikidata - awgldk - TriplyDB

Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.

Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.

http://www.wikidata.org/entity/Q39158096

about

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential Psoriasis induced by thalidomide in a patient with multiple myeloma Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

P2860

Q28075927-9E8762FE-446F-4832-BCBC-46857B3B3738 Q33833466-3C850B53-AA4B-4019-96D9-BB1F4A5A8CD3 Q35834665-37FDC186-538F-4AEF-89C7-F5758D1B67E3 Q36413655-EF327922-0FEA-48A9-AD3A-4C546B8B6F9A Q37325843-79A99FB8-0C5C-4188-B7AC-F8FDD2C905FA Q38896657-3EBAF3F0-17CF-436B-B062-83FF362D7B20 Q38968027-DAA3C5CF-0AE2-4F91-B5EF-0737A26BC81F Q42111039-DCB89183-D13B-4623-8611-4332BC1DD997 Q42923841-5CD9A232-215D-4A30-A96A-B0B5A333D6D1 Q45756098-35624467-2D28-4460-92FB-0EF86D93650F Q50197484-AB3D4967-49BF-4D78-B79C-3C066C7700FB

P2860

Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.

http://www.wikidata.org/entity/Q39158096

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@en

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@nl

type

label

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@en

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@nl

prefLabel

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@en

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@nl

P1433

Q39158096-7B5A4C8B-4D90-4DB8-A88C-C4F92B031786

P1476

Q39158096-1C8A3251-29B8-466E-8E88-73A0525ECF9D

P2093

Q39158096-222BFC5F-9BDC-49C7-9D9D-B1635F0E43F5

Q39158096-97131D4C-C77A-4E58-BD7A-6DF09DF51E9E

Q39158096-C1FA80E8-BC63-47CC-AD52-5E4F01290AD8

Q39158096-C49F8E1B-E0F4-4286-9D0D-F84748B3DCFB

Q39158096-D4AB4C08-3399-45A7-B299-C6A81A80B409

Q39158096-E21A93BB-86E5-4BBA-A037-D0CF4F7D3503

Q39158096-E613079B-6D35-4E4C-B932-B6BB1AD647EA

Q39158096-FC98126F-81AA-4BD1-95CF-F5A0BBE5B24C

P2860

Q39158096-0B792A4D-AADD-4B92-AFD0-B4C4575F32AB

Q39158096-1103F916-7094-4027-BF97-DA02250A49F8

Q39158096-138940A3-9254-4209-A0D2-AC3F9A1DA59F

Q39158096-17940FEE-99AA-41A8-A3B0-3BDCC3481A73

Q39158096-1D94629E-3704-4A3E-BC8F-8BED1620A5CF

Q39158096-4C8E1260-7A74-438A-A9E5-2AB015AECD3F

Q39158096-52366DC0-22C4-4EAC-BAE5-2D8750E4272D

Q39158096-5AC9C611-2F89-46A0-B0F6-A43603276FD0

Q39158096-6AAD8988-EF11-4216-A404-C7B1D086E4B1

Q39158096-82A8CF3D-059D-41C9-8C3C-B7C33CEACEEB

P2888

Q39158096-8D9BBE09-B96C-4F8D-AC33-F75E97DA21E4

P304

Q39158096-BC0A45B0-9D65-46C0-9D68-84C89D71ADE7

P31

Q39158096-DDEDA2D5-9098-4196-9303-149E66700106

P356

Q39158096-CA939349-1683-4586-850A-F1489064F027

P407

Q39158096-DA3E529C-E54B-4B38-A3E9-55325250F9F8

P433

Q39158096-99ECCF12-53BF-4353-A51E-A20E12D534EC

P478

Q39158096-B257B563-DC05-4365-A8D1-ED54006D15E1

P577

Q39158096-6A2C08F9-71F4-4C52-BBFB-364A8A10EEA7

P5875

Q39158096-13921944-CDA5-4002-A5EF-C078EF08EC5A

P6179

Q39158096-9A6A4337-7448-4DA3-A9A6-B7AB393BEC65

P698

Q39158096-B7A113F8-9C67-4A3E-B443-008218C97943

P932

Q39158096-57678A2F-14BC-40FC-B8BF-46D1165CDC42

P356

P1433

British Journal of Cancer

P1476

Paradoxical effect of lenalido ...... profiles in multiple myeloma.

@en

P2093

C Gratas

http://www.w3.org/2001/XMLSchema#string

C Pellat-Deceunynck

http://www.w3.org/2001/XMLSchema#string

M Amiot

http://www.w3.org/2001/XMLSchema#string

P Gomez-Bougie

http://www.w3.org/2001/XMLSchema#string

P Moreau

http://www.w3.org/2001/XMLSchema#string

S Bonnaud

http://www.w3.org/2001/XMLSchema#string

S Le Gouill

http://www.w3.org/2001/XMLSchema#string

S Maïga

http://www.w3.org/2001/XMLSchema#string

P2860

A new mathematical model for relative quantification in real-time RT-PCR

Insulin and insulin-like growth factor signalling in neoplasia

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.

Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production.

Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.

Lenalidomide after stem-cell transplantation for multiple myeloma

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.

Lenalidomide: a new therapy for multiple myeloma.

P2888

P304

1801-1806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.186

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236599209

http://www.w3.org/2001/XMLSchema#string

P6179

1000616297

http://www.w3.org/2001/XMLSchema#string

P698

23632478

http://www.w3.org/2001/XMLSchema#string

P932

3658519

http://www.w3.org/2001/XMLSchema#string